If you've spent any time researching weight loss medications, you've probably seen two terms used almost interchangeably: GLP-1s and peptides. They show up in the same conversations, the same forums, sometimes even the same treatment plans — but they're not the same thing.

Here's the part that makes it confusing: GLP-1 medications are technically peptides. But when most people say "peptides," they're referring to something else entirely.

Let's untangle it.

What Is a Peptide, Exactly?

A peptide is simply a short chain of amino acids — the building blocks of proteins. Your body produces thousands of peptides naturally. They act as chemical messengers, telling your cells what to do: heal tissue, release hormones, regulate appetite, and more.

When people in the wellness and weight loss world talk about "peptides," they're usually referring to therapeutic peptides — lab-made compounds designed to mimic or enhance specific functions in the body. Popular examples include BPC-157 (used for gut healing and tissue repair), CJC-1295 and Ipamorelin (which stimulate growth hormone release), and Tesamorelin (used for reducing abdominal fat).

These peptides are typically obtained through specialty clinics or compounding pharmacies, and most are not FDA-approved for the purposes they're commonly used for.

What Are GLP-1 Medications?

GLP-1 stands for glucagon-like peptide-1, a hormone your gut naturally releases after you eat. It helps regulate blood sugar, slows digestion, and signals to your brain that you're full.

GLP-1 receptor agonists — the medications you know as Ozempic (semaglutide), Mounjaro (tirzepatide), Wegovy, and Zepbound — are lab-engineered versions of that hormone. They bind to GLP-1 receptors in your body and amplify the effects: stronger appetite suppression, better blood sugar control, and slower gastric emptying.

These medications have gone through rigorous clinical trials and are FDA-approved for type 2 diabetes and/or chronic weight management. They're prescribed by doctors, covered by many insurance plans, and backed by large-scale safety data.

So yes — semaglutide is a peptide. But it's an FDA-approved, extensively studied, highly regulated one.

The Key Differences That Actually Matter

Here's where it gets practical:

Regulation and safety data. GLP-1 medications like semaglutide and tirzepatide have years of clinical trial data behind them, involving tens of thousands of patients. Most therapeutic peptides (BPC-157, CJC-1295, etc.) have limited human data — much of the evidence comes from animal studies or anecdotal reports.

How they work. GLP-1 medications primarily reduce appetite and improve metabolic function through well-understood receptor pathways. Other peptides work through different mechanisms entirely — growth hormone release, tissue repair, inflammation reduction — and target different goals.

How they're obtained. GLP-1s are prescribed through standard medical channels. Many other peptides come from compounding pharmacies, which the FDA has flagged for inconsistent quality control and dosing accuracy. This doesn't mean compounded peptides are inherently dangerous, but it does mean the oversight is different.

What they're used for. GLP-1 medications are specifically designed for blood sugar management and weight loss. Other peptides serve a wide range of purposes — from muscle recovery to gut healing to anti-aging — and are sometimes used alongside GLP-1s to manage side effects or support overall health.

Can You Use Both?

Some people do. It's increasingly common to see treatment plans that combine a GLP-1 medication with one or more therapeutic peptides — for example, using BPC-157 to support gut health while on semaglutide, or adding a growth hormone peptide to help preserve lean muscle during weight loss.

If you're managing multiple injections with different schedules, doses, and injection sites, that's where things get complicated fast. An app like Gilly can help you keep track of each medication separately — so you always know what you took, when, and where you injected it.

The Bottom Line

GLP-1 medications and therapeutic peptides aren't competing categories — they're overlapping ones. GLP-1s are a specific, well-regulated subset of peptides with strong clinical backing. Other peptides serve different purposes and come with less regulatory oversight.

Understanding the difference helps you have better conversations with your doctor, make more informed decisions about your treatment plan, and — if you're tracking multiple medications in Gilly — know exactly what each one is doing for you.

This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before starting, stopping, or changing any medication or treatment plan.